Taurocholic acid ameliorates hypertension through the activation of TGR5 in the hypothalamic paraventricular nucleus

Insufficient TCA may contribute to the pathogenesis of hypertension. PVN supplementation of TCA can activate TGR5 in neurons and microglia, downregulate inflammatory responses, suppress oxidative stress, and eventually ameliorate hypertension.